0001193125-17-172061.txt : 20170628 0001193125-17-172061.hdr.sgml : 20170628 20170516160057 ACCESSION NUMBER: 0001193125-17-172061 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 CORRESP 1 filename1.htm CORRESP

Antares Pharma, Inc.

100 Princeton South, Suite 300

Ewing, NJ 08628

May 16, 2017

VIA EDGAR TRANSMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:     Amanda Ravitz, Assistant Director, Office of Electronics and Machinery
    Caleb French

 

Re:    Antares Pharma, Inc.
   Registration Statement on Form S-3
   Filed May 9, 2017
   File No. 333-217808

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Antares Pharma, Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-217808), so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on May 18, 2017, or as soon as practicable thereafter.

 

ANTARES PHARMA, INC.
By:  

/s/ Fred M. Powell

Name:   Fred M. Powell
Title:   Senior Vice President and Chief Financial Officer